Inactive Instrument

SANUWAVE Health, Inc. Share Price Other OTC

Equities

SNWV

US80303D1072

Medical Equipment, Supplies & Distribution

Sales 2022 16.74M 1.34B Sales 2023 20.4M 1.63B Capitalization 14.83M 1.19B
Net income 2022 -10M -801M Net income 2023 -25M -2B EV / Sales 2022 3.13 x
Net Debt 2022 39.95M 3.2B Net Debt 2023 30.15M 2.41B EV / Sales 2023 2.2 x
P/E ratio 2022
-1.14 x
P/E ratio 2023
-0.4 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 04/08/22
President 39 30/07/23
Chief Operating Officer 63 28/02/06
Members of the board TitleAgeSince
Director/Board Member 54 31/07/05
Chief Executive Officer 51 04/08/22
Director/Board Member 52 17/04/16
More insiders
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.
More about the company